We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MedImmune Licenses BioWa’s POTELLIGENT™ Technology

News   Dec 07, 2005

 
MedImmune Licenses BioWa’s POTELLIGENT™ Technology
 
 
 

RELATED ARTICLES

Deep Learning Helps Tease Out Gene Interactions

News

Convolutional neural networks could be used to help identify disease-related genes and genetic pathways that could be targets for drugs.

READ MORE

Gut Feeling: A Network-based Approach Towards Understanding IBD

News

Scientists have discovered how to get detailed transcriptomics data from gut organoids, and regulatory networks to analyze them, establishing a pipeline that can be used to explore the causes of inflammatory bowel disease.

READ MORE

Strategic Plan To Cure Hepatitis B in the Making

News

A new strategy from NIH outlines efforts to intensify ongoing hepatitis B research with goals including developing a cure and improving scientific understanding of the virus.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE